2016 Hunter Cancer Research Symposium
Date: Friday 25th November 2016
The overarching theme of this Symposium is “Leading translational research for improved patient outcomes”.
This Symposium will cover the full spectrum of the translational research-to-practice continuum from basic science to clinical research and implementation research. We believe bringing together people from diverse research and clinical areas will ensure an invaluable forum for all participants.
Abstract Submission: Now Closed
Monday 12th September 2016: Notification of presentation outcomes sent
Associate Professor Sarah-Jane Dawson
Group Leader, Molecular Biomarkers and Translational Genomics Laboratory, Peter MacCallum Cancer Centre
Title of Presentation: “Liquid Biopsies: Monitoring the Cancer Genome in Blood’
Associate Professor Sarah-Jane Dawson is a clinician-scientist. She obtained her medical degree from the University of Melbourne, and trained as an oncologist in Melbourne, Australia. She completed her PhD at the University of Cambridge, UK. Following postdoctoral studies at the Cambridge Research Institute, she returned to Melbourne in 2014 to head the newly formed Molecular Biomarkers and Translational Genomics Laboratory at the Peter MacCallum Cancer Centre.
Her current research interests lie in understanding the genomic evolution of cancer and using this information to develop noninvasive molecular biomarkers for clinical application, including early detection, risk stratification and disease monitoring. The major focus of her research is the development of blood-based biomarkers ('liquid biopsies') through the use of circulating tumour DNA (ctDNA) and circulating tumour cells (CTC)) to enable personalised disease monitoring and facilitate therapeutic decisions in both solid and haematological malignancies.
Adjunct Associate Professor Nikolajs Zeps
Director, Medical Research Network, St John of God Subiaco Hospital
Title of Presentation: "Integrating research into routine clinical care: turning the dream of a self improving healthcare system into reality"
Dr. Zeps is a PhD scientist involved in translational research in breast, gastrointestinal and gynecological malignancies. He is the Director of Research at SJG Health Care and head of a translational research program that has established a biobank and clinical registry as a part of routine multidisciplinary cancer care.
He is an Adjunct Professor in the School of Health Sciences at Curtin University, the Centre for Comparative Genomics at Murdoch University and at Notre Dame Medical School. He is an Adjunct Associate Professor in the School of Surgery and the School of Pathology and Laboratory Medicine at the University of Western Australia.
He was a member of the Australian Health Ethics Committee from 2006-2012 and the Research Committee of the National Health and Medical Research Council (NHMRC) of Australia from 2009-2015.
He is the chair of the Cancer Biology Group of the Clinical Oncology Society of Australia and a member of the Scientific Advisory Committee of the Australasian Gastro-intestinal Trials Group and of the Primary Care Cancer Collaborative Trials Group Executive committee. His is a founding director of the Australian Clinical Trials Alliance.
He is the Australian representative on the Ethics and Policy Committee of the International Cancer Genome Consortium (ICGC) and was recently appointed Co-Chair of the Communication Committee of the ICGC-Precision Medicine initiative. He is a member of the Accountability Working Group of the Global Alliance for Genomic Health (GA4GH). He was the Australian member of the Steering Committee for the Global Summit.